Barbara Olendzki to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Barbara Olendzki has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.195
-
Ma Y, Culver A, Rossouw J, Olendzki B, Merriam P, Lian B, Ockene I. Statin therapy and the risk for diabetes among adult women: do the benefits outweigh the risk? Ther Adv Cardiovasc Dis. 2013 Feb; 7(1):41-4.
Score: 0.090
-
Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahilly-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med. 2012 Jan 23; 172(2):144-52.
Score: 0.085
-
McDermott MM, Reed G, Greenland P, Mazor KM, Pagoto S, Ockene JK, Graff R, Merriam PA, Leung K, Manheim L, Kibbe MR, Olendzki B, Pearce WH, Ockene IS. Activating peripheral arterial disease patients to reduce cholesterol: a randomized trial. Am J Med. 2011 Jun; 124(6):557-65.
Score: 0.020